Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
ItalyStudy on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia
ItalyStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
ItalyStudy of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia
ItalyStudy of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
ItalyStudy of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
ItalyStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
ItalyStudy on Cemiplimab and OSE2101 for Maintenance Therapy in Patients with ctDNA Positive Non-Small Cell Lung Cancer (NSCLC)
ItalyStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
ItalyStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
ItalyLong-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome
ItalyStudy of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
